Alebund Pharmaceutical raised $75 million in Series C funding led by unnamed healthcare fund to support development and commercial activities of its renal disease pipeline.
Amount Raised
$75 Million
Round Type
Series C
ShanghaiBiotechnologyHealth CarePharmaceuticalInvestors
Description
Alebund Pharmaceutical secured RMB 550 million (approximately $75 million) in a Series C funding round. The proceeds will assist in the firm's Chinese new drug application and global pivotal study for its iron-based phosphate binder AP301, among other expansion efforts.
Quick answer
Alebund Pharmaceutical raised $75 Million in a Series C round, dated January 7, 2025. Investors: Yangzhou Guojin Investment Group and Kingray Capital. Alebund Pharmaceutical is based in Shanghai, Shanghai, China.
- How much did Alebund Pharmaceutical raise?
- Alebund Pharmaceutical raised $75 Million in a Series C round on January 7, 2025.
- Who invested in Alebund Pharmaceutical?
- Yangzhou Guojin Investment Group and Kingray Capital are named as investors in this round.
- What does Alebund Pharmaceutical do?
- Alebund was incubated in Shanghai in 2018.
- Where is Alebund Pharmaceutical based and how big is it?
- Alebund Pharmaceutical is based in Shanghai, Shanghai, China. Fundz records about 3 employees.
- Who are the decision-makers at Alebund Pharmaceutical?
- Fundz holds 1 contact at Alebund Pharmaceutical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Pharmaceutical and Biotechnology around the same time
Companies in the same sectors as Alebund Pharmaceutical that raised within 45 days of this round, from Fundz verified event records.
- Acasti raised $15M on February 10, 2025.
- Phlow raised $31M on January 31, 2025.
- NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
- Neumirna Therapeutics raised $20M (Series A) on January 13, 2025.
- Windward Bio raised $200M (Series A) on January 10, 2025.
- Verdiva Bio raised $411M (Series A) on January 9, 2025.
Who to call at Alebund Pharmaceutical, and when
A new round usually means Alebund Pharmaceutical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alebund Pharmaceutical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alebund Pharmaceutical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alebund Pharmaceutical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alebund Pharmaceutical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alebund Pharmaceutical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.